1. MARKETS
  2. SECTOR : BANKING AND FINANCE
  3. INDUSTRY : INVESTMENT TRUSTS/MUTUAL FUNDS
  4. TEKLA LIFE SCIENCES INVESTORS
Tekla Life Sciences Investors XNYS: HQL
Download real time
13.24 -0.03 (-0.23%)
25.50% Gain from 52W Low
88,135
XNYS Volume

XNYS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share


Insider Trading disclosures for Tekla Life Sciences Investors

The latest disclosure was made by C. William Maher in Tekla Life Sciences Investors where a trade of 650 Common Stock done at an average price of $15.4 was reported to US exchanges on Aug. 23, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
C. William Maher Director Purchase of securities on an exchange or from another person at price $ 15.37 per share. 23 Aug 2024 650 1,715 (0%) 0% 15.4 9,991 Common Stock
Rose DiMartino Director Purchase of securities on an exchange or from another person at price $ 15.53 per share. 16 Jul 2024 1,000 1,000 (0%) 0% 15.5 15,530 Common Stock
Kathleen L. Goetz Director Purchase of securities on an exchange or from another person at price $ 13.32 per share. 09 Apr 2024 400 1,085 (0%) 0% 13.3 5,327 Common Stock
Todd Reit Director Purchase of securities on an exchange or from another person at price $ 13.80 per share. 02 Jan 2024 1,000 1,000 (0%) 0% 13.8 13,798 Common Stock
Maher C. William Director Purchase of securities on an exchange or from another person at price $ 13.57 per share. 28 Dec 2023 1,000 1,000 (0%) 0% 13.6 13,570 Common Stock
Daniel R. Omstead Director, President 25 Sep 2023 10,096 197,518 (0%) 0% 12.4 125,116 Shares of Beneficial Interest
Daniel R. Omstead Director, President 20 Sep 2023 12,000 187,422 (0%) 0% 12.7 152,206 Shares of Beneficial Interest
Kathleen Goetz Director Purchase of securities on an exchange or from another person at price $ 16.33 per share. 23 Mar 2022 92 685 (0%) 0% 16.3 1,502 Shares of Beneficial Interest
Kathleen Goetz Director Purchase of securities on an exchange or from another person at price $ 17.54 per share. 26 Jan 2022 593 593 (0%) 0% 17.5 10,404 Shares of Beneficial Interest
Daniel R. Omstead Director, President 11 Aug 2021 6,403 146,489 (0%) 0% 21.6 138,497 Shares of Beneficial Interest
Daniel R. Omstead Director, President 21 Oct 2020 5,950 125,660 (0%) 0% 17.7 105,606 Shares of Beneficial Interest
Daniel R. Omstead Director, President 21 May 2020 5,950 114,820 (0%) 0% 17.7 105,557 Shares of Beneficial Interest
Daniel R. Omstead Director, President 17 Mar 2020 8,300 105,813 (0%) 0% 13.3 110,107 Shares of Beneficial Interest
Thomas M. Kent None Purchase of securities on an exchange or from another person at price $ 21.04 per share. 25 Jan 2018 1,300 1,300 (0%) 0% 21.0 27,348 Shares of Beneficial Interest
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters